Abstract
SummaryLaboratory medicine and clinical medicine are co-dependent components of medicine. Laboratory medicine functions most effectively when focused through a clinical lens. Me dical practice as a whole undergoes change. New drugs, treatments and changes in management strategies are introduced. New techniques, new technologies and new tests are developed. These changes may be either clinically or laboratory initiated, and so their introduction requires dialogue and interaction between clinical and laboratory medicine specialists. Treatment monitoring is integral to laboratory medicine, varying from direct drug measurement to monitoring cholesterol levels in response to treatment. The current trend to »personalised medicine« is an extension of this process with the development of companion diagnostics. Technological innovation forms part of modern laboratory practice. Introduction of new technology both facilitates standard laboratory approaches and permits introduction of new tests and testing strategies previously confined to the research laboratory only. The revolution in cardiac biomarker testing has been largely a laboratory led change. Flexibility in service provision in response to changing clinical practice or evolving technology provides a significant laboratory management challenge in the light of increasing expectations, shifts in population demographics and constraint in resource availability. Laboratory medicine practitioners are adept at meeting these challenges. One thing remains constant, that there will be a constant need laboratory medicine to meet the challenges of novel clinical challenges from infectious diseases to medical conditions developing from lifestyle and longevity.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference21 articles.
1. Non - alcoholic fatty liver disease;Sattar;BMJ,2014
2. Use of low - density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia : a casecontrol study;Talmud;Lancet,2013
3. A note on the spectrometric assay of glutamic - oxalacetic transaminase in human blood serum;Karmen;J Clin Invest,1955
4. Early diagnosis of myocardial infarction by timed sequential enzyme measurements;Collinson;Ann Clin Biochem,1988
5. Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients : Results From the Multicenter Procalcitonin MOnitoring SEpsis Study;Schuetz;Crit Care Med,2017
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献